Mikkel Christensen
About
In The Last Decade
Mikkel Christensen
154 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Endocrinology, Diabetes and Metabolism 3.9k
- Surgery 2.1k
- Molecular Biology 1.8k
- Physiology 915
- Pharmacology 809
Countries citing papers authored by Mikkel Christensen
This map shows the geographic impact of Mikkel Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikkel Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikkel Christensen more than expected).
Fields of papers citing papers by Mikkel Christensen
This network shows the impact of papers produced by Mikkel Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikkel Christensen. The network helps show where Mikkel Christensen may publish in the future.
Co-authorship network of co-authors of Mikkel Christensen
This figure shows the co-authorship network connecting the top 25 collaborators of Mikkel Christensen. A scholar is included among the top collaborators of Mikkel Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikkel Christensen. Mikkel Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 27 | |
| 10 | 34 | |
| 11 | 16 | |
| 12 | 36 | |
| 13 | 15 | |
| 14 | 4 | |
| 15 | An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions. | 6 |
| 16 | 4 | |
| 17 | No clinical value of post-operative routine X-ray following uncomplicated cementless primary total hip arthroplasty. | 8 |
| 18 | 31 | |
| 19 | Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus. | 60 |
| 20 | An improved procedure for conducting lactic acid stinging tests on facial skin | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.